Physician

Kamil I Hanna, MD

According to 2025 Medicare claims, Kamil Hanna, MD (NPI: 1881632099) practices cardiac electrophysiology in the Valdosta, GA market, with the plurality of this provider's patient population coming from Lowndes, GA. This provider's primary affiliated billing organization is SGMC PHYSICIAN NETWORK INC (NPI: 1417597170; TIN: 84-3707279) and primary practice location at 31602-1735. Hanna is affiliated with the PRIVIA QUALITY NETWORK - I LLC (ACO ID: A5533), participating under the MSSP model.

Hanna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 558 traditional Medicare patients, billed 4,008 HCPCS/CPT codes, and received $209,472 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,881 prescription claims across 557 beneficiaries totaling $910,175 in drug costs, led by Eliquis (Apixaban). DME data shows 265 claims. Open Payments data shows 85 records totaling $6,424. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $165,240 to $910,175. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $91,878 to $37,028.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$113K$226K2015 Medicare payment: $220,163 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $199,488 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $194,180 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $195,441 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $226,125 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $166,652 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $161,439 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $158,268 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $192,003 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $209,472 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0894,585$220,163
20161,1754,845$199,488
20178184,582$194,180
20188024,948$195,441
20198375,119$226,125
20207524,491$166,652
20217944,209$161,439
20223622,212$158,268
20234723,355$192,003
20245584,008$209,472

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$455K$910K2015 Drug cost: $165,240 (USD; Tot_Drug_Cst)2016 Drug cost: $228,706 (USD; Tot_Drug_Cst)2017 Drug cost: $312,845 (USD; Tot_Drug_Cst)2018 Drug cost: $378,742 (USD; Tot_Drug_Cst)2019 Drug cost: $519,747 (USD; Tot_Drug_Cst)2020 Drug cost: $649,550 (USD; Tot_Drug_Cst)2021 Drug cost: $844,194 (USD; Tot_Drug_Cst)2022 Drug cost: $528,760 (USD; Tot_Drug_Cst)2023 Drug cost: $597,412 (USD; Tot_Drug_Cst)2024 Drug cost: $910,175 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153342,917$165,240
20163673,257$228,706
20174073,668$312,845
20184183,825$378,742
20194974,170$519,747
20205304,397$649,550
20216085,092$844,194
20225322,917$528,760
20234243,085$597,412
20245574,881$910,175

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$46K$92K2015 Medicare payment: $91,694 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $55,525 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $44,248 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $49,293 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $29,480 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $28,566 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $28,576 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $4,866 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $9,525 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151746$91,694
2016N/R29$55,525
2017N/R23$44,248
2018N/R25$49,293
2019N/R14$29,480
2020N/RN/RN/R
2021N/R13$28,566
2022N/R12$28,576
202338108$4,866
202466265$9,525

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more131131$105
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more336459$85
93294Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days180411$20
93296Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days219615$13
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report430620$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban61525,930$493,508
XareltoRivaroxaban26711,113$206,928
EntrestoSacubitril/Valsartan672,790$60,706
MounjaroTirzepatide30848$31,170
MultaqDronedarone Hcl341,310$29,243

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0601Continuous positive airway pressure (cpap) deviceY20109$3,828
A7030Full face mask used with positive airway pressure device, eachNN/R17$1,495
A7031Face mask interface, replacement for full face mask, eachNN/R12$1,049
A4604Tubing with integrated heating element for use with positive airway pressure deviceN1424$981
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R12$817

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.85$6,424Medtronic, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kamil I. Hanna, MD?

Tedicare shows public-source Medicare data for Kamil I. Hanna, MD (NPI 1881632099), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kamil I. Hanna, MD have ACO affiliation data?

Kamil I. Hanna, MD is shown with ACO affiliation data for PRIVIA QUALITY NETWORK - I LLC (MSSP, ACO ID A5533).

What billing organization is linked to Kamil I. Hanna, MD?

Kamil I. Hanna, MD is linked to SGMC PHYSICIAN NETWORK INC (billing NPI 1417597170) in the available physician profile data.

Does Kamil I. Hanna, MD have Open Payments data?

Kamil I. Hanna, MD has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.